Nuvation Bio Inc. (NUVB) is a publicly traded Healthcare sector company. As of October 21, 2026, NUVB trades at $4.92 with a market cap of $1.67B and a P/E ratio of -11.24. NUVB moved +3.98% today. Year to date, NUVB is -43.47%; over the trailing twelve months it is +15.20%. Its 52-week range spans $1.54 to $9.75. Analyst consensus is strong buy with an average price target of $14.57. Rallies surfaces NUVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for NUVB shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $4.92 |
| Market Cap | $1.67B |
| P/E Ratio | -11.24 |
| EPS | $-0.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.75 |
| 52-Week Low | $1.54 |
| Volume | 1.56M |
| Avg Volume | 0 |
| Revenue (TTM) | $169.90M |
| Net Income | $-149.83M |
| Gross Margin | 0.00% |
9 analysts cover NUVB: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.57.